Antibiotics are the old medicine cabinet standby for treating infections caused by multidrug-resistant Staphylococcus aureus, but as antimicrobial resistance continues to mount globally, scientists ...

Staphylococcus aureus remains a leading cause of hospital- and community-acquired infections worldwide, ranging from superficial skin lesions to life-threatening pneumonia and sepsis. Proteomic ...

Staphylococcus aureus employs a multifaceted arsenal of molecular strategies to colonise tissues, evade host defences and establish infection. Surface adhesins mediate attachment to host extracellular ...

Recently, a research team led by Prof. Sun Baolin from the University of Science and Technology of China (USTC) revealed the mechanism of transcriptional regulation via S-nitrosylation for vancomycin ...

After dozens of clinical trials, there are still no effective vaccines against Staphylococcus aureus. In two new studies, scientists report that the pathogen turns on the protein interleukin 10, ...

Dokland’s study, “Shape shifter: redirection of prolate phage capsid assembly by staphylococcal pathogenicity islands” was published in Nature Communications. Dokland said that Bacteriophages or ...

A promising approach to control Staphylococcus aureus bacterial colonization in people—using a probiotic instead of antibiotics—was safe and highly effective in a Phase 2 clinical trial. The new study ...

Staphylococcus aureus (S. aureus) has a complicated relationship with humans. While this commensal bacterium colonizes approximately 20-30 percent of human nasal cavities and is a member of the human ...

SCHLIEREN, Switzerland--(BUSINESS WIRE)--LimmaTech Biologics AG, a clinical-stage biotech company developing vaccines for the prevention of life-threatening diseases, announced today that the U.S.